← FDA DRUG APPROVALS

FDA ANDA · ANDA206018

MELPHALAN HYDROCHLORIDE

Sponsor: ACTAVIS LLC

APPLICATION
ANDA206018
TYPE
ANDA
ORIGINAL APPROVAL
2016-12-19
LATEST ACTION
2023-05-15
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MELPHALAN HYDROCHLORIDEPrescription
MELPHALAN HYDROCHLORIDE EQ 50MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2023-05-15Labeling · Supplement 2 · standardAP
2016-12-19UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →